International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic or Biphenotypic Leukemia

Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title

Protocol ID

Interfant-06

Disease (Sub Disease)

Leukaemia

Sponsor

Australian and New Zealand Children's Haematology Oncology Group
Dutch Childhood Oncology Group

Collaborators

BFM Germany
CORS Monza Italy
Associazione Italiana Ematologia Oncologia Pediatrica
BFM Austria
CLCG France Belgium Portugal
COALL Germany
CPH, Czech republic
DFCI consortium USA
FRALLE France
Hong Kong
MD Anderson USA
NOPHO Scandinavian countries
PINDA, Chile
PPLLSG Poland
Seattle USA
SJCRH USA
UKCCSG United Kingdom

Trial Status

Closed to Recruitment

Study Type

Registry

Phase

Phase 3

Age Eligibility

up to 1 year

International registry ID's

NCT00550992

Back to Registry

Study Title	International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic or Biphenotypic Leukemia
Protocol ID	Interfant-06
Disease (Sub Disease)	Leukaemia
Sponsor	Australian and New Zealand Children's Haematology Oncology Group/ Dutch Childhood Oncology Group
Collaborators	BFM Germany/ CORS Monza Italy/ Associazione Italiana Ematologia Oncologia Pediatrica/ BFM Austria/ CLCG France Belgium Portugal/ COALL Germany/ CPH, Czech republic/ DFCI consortium USA/ FRALLE France/ Hong Kong/ MD Anderson USA/ NOPHO Scandinavian countries/ PINDA, Chile/ PPLLSG Poland/ Seattle USA/ SJCRH USA/ UKCCSG United Kingdom
Trial Status	Closed to Recruitment
Trial Open Date	15/01/2006
Study Type	Registry
Phase	Phase 3
Age Eligibility	up to 1 year
International registry ID's	NCT00550992